期刊
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
卷 11, 期 1, 页码 99-102出版社
CIG MEDIA GROUP, LP
DOI: 10.3816/CLML.2011.n.019
关键词
-
The distinction between WM and SMZL may be difficult since both entities share overlapping clinical immunophenotypic, and histopathologic characteristics. In this context we evaluated whether CD 138 expression could be added in the armamentarium of tools used to differentiate these entities. Sixty-nine patents were studied, 47 WM and 22 SMZL. Paraffin-embedded sections of hone marrow biopsies were quantitatively and qualitatively evaluated for CD138 expression. Sixty percent of WM cases expressed CD138 in contrast to 18% of SMZL patients. Intermediate/high intensity of CD 138 expression was observed in 47% of WM while it was low in all SMZL patients. Differences between WM and SMZL regarding the intensity and the percentage of CD138 positive cells were both significant (P = .0008 and, .00021 respectively). Moreover, CD138 expression was related to serum IgM levels in WM patients (P = .0006). In conclusion, CD138 expression may constitute an additional aid in the distinction between WM and SMZL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据